# CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

> **NCT01540604** · PHASE2 · COMPLETED · sponsor: **RSPR Pharma AB**

## Conditions studied

- Duchenne Muscular Dystrophy
- Becker Muscular Dystrophy

## Interventions

- **DRUG:** CRD007

## Key facts

- **NCT ID:** NCT01540604
- **Lead sponsor:** RSPR Pharma AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2012-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01540604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01540604, "CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01540604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*